GE HealthCare Files 8-K
Ticker: GEHC · Form: 8-K · Filed: Sep 13, 2024 · CIK: 1932393
| Field | Detail |
|---|---|
| Company | Ge Healthcare Technologies Inc. (GEHC) |
| Form Type | 8-K |
| Filed Date | Sep 13, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.01, $86.00 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k, financials
TL;DR
GE HealthCare filed an 8-K, mostly boilerplate financial and exhibit updates.
AI Summary
GE HealthCare Technologies Inc. filed an 8-K on September 13, 2024, reporting on events from September 12, 2024. The filing primarily concerns financial statements and exhibits, with no specific material events detailed in the provided text.
Why It Matters
This filing indicates routine corporate reporting by GE HealthCare Technologies Inc. to the SEC, providing updates on financial statements and exhibits.
Risk Assessment
Risk Level: low — The filing appears to be routine and does not disclose any new material risks or significant events.
Key Numbers
- 001-41528 — Commission File Number (Identifier for GE HealthCare's SEC filings)
- 88-2515116 — IRS Employer Identification No. (Tax identification number for GE HealthCare)
Key Players & Entities
- GE HealthCare Technologies Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- September 12, 2024 (date) — Earliest event reported
- September 13, 2024 (date) — Filing date
FAQ
What specific financial statements or exhibits are being reported in this 8-K filing?
The provided text indicates that the filing concerns 'Financial Statements and Exhibits' but does not list the specific documents included.
What is the exact date of the earliest event reported in this filing?
The earliest event reported is dated September 12, 2024.
What is the principal executive office address for GE HealthCare Technologies Inc.?
The principal executive offices are located at 500 W. Monroe Street, Chicago, IL 60661.
What is the former name of GE HealthCare Technologies Inc.?
The former name was GE Healthcare Holding LLC.
What is the SIC code for GE HealthCare Technologies Inc.?
The Standard Industrial Classification (SIC) code is 3844, pertaining to X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS.
Filing Stats: 1,008 words · 4 min read · ~3 pages · Grade level 10.7 · Accepted 2024-09-13 17:24:32
Key Financial Figures
- $0.01 — ich registered Common stock, par value $0.01 per share GEHC The Nasdaq Stock Mar
- $86.00 — Shares") at a public offering price of $86.00 per share. The Company is not selling a
Filing Documents
- d834155d8k.htm (8-K) — 29KB
- d834155dex11.htm (EX-1.1) — 152KB
- d834155dex991.htm (EX-99.1) — 9KB
- 0001193125-24-218963.txt ( ) — 354KB
- gehc-20240912.xsd (EX-101.SCH) — 3KB
- gehc-20240912_lab.xml (EX-101.LAB) — 17KB
- gehc-20240912_pre.xml (EX-101.PRE) — 11KB
- d834155d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d)Exhibits 1.1 Underwriting Agreement, dated September 12, 2024, among GE HealthCare Technologies Inc., General Electric Company, Morgan Stanley & Co. LLC, as selling stockholder, and Morgan Stanley & Co. LLC and Citigroup Global Markets Inc., as representatives of the several underwriters named therein. 99.1 Press Release of GE HealthCare Technologies Inc., dated September 12, 2024. 104 The cover page from this Current Report on Form 8-K is formatted in Inline XBRL
Forward Looking Statements
Forward Looking Statements This Current Report on Form 8-K and Exhibit 99.1 hereto contain "forward-looking statements", including statements regarding the Offering. These forward-looking statements might be identified by words, and variations of words, such as "will," "expect," "may," "would," "could," "plan," and similar expressions. These forward-looking statements reflect management's current plans, estimates and expectations and are inherently uncertain. The inclusion of any forward-looking information in this document should not be regarded as a representation that the future plans, estimates or expectations contemplated will be achieved. These forward-looking statements involve risks and uncertainties, many of which are beyond the Company's control. Factors that could cause actual results to differ materially from those described in the Company's forward-looking statements include, but are not limited to, risks and uncertainties associated with market conditions and the satisfaction of customary closing conditions related to the Offering, and the other factors detailed in the Company's Registration Statement on Form S-3 filed with the U.S. Securities and Exchange Commission (the "SEC") on February 15, 2024, as well as other risks discussed in the Company's filings with the SEC. Please also see the "Risk Factors" section of the Company's Form 10-K filed with the SEC and any updates or amendments it makes in future filings. There may be other factors not presently known to the Company or which it currently considers to be immaterial that could cause the Company's actual results to differ materially from those projected in any forward-looking statements the Company makes. The Company does not undertake any obligation to update or revise its forward-looking statements except as required by applicable law or regulation.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 13, 2024 GE HealthCare Technologies Inc. (Registrant) /s/ Frank R. Jimenez Frank R. Jimenez, General Counsel and Corporate Secretary (authorized signatory)